Why the study?
Do implanted pervenous demand pacemakers terminate and prevent recurrent tachycardias in patients refractory to medical therapy?
Population
3 patients with recurrent paroxysmal tachycardia refractory to antiarrhythmic drugs, with tachycardia rates…
Design
Case_series
Follow-up
2 to 7 months
Authors
Loading...
May support pacemakers for refractory SVT/VT in select cases; leaves open need for prospective trials before broader adoption.
Do implanted pervenous demand pacemakers terminate and prevent recurrent tachycardias in patients refractory to medical therapy?
Implanted pervenous pacemakers can effectively terminate and prevent recurrent, drug-refractory supraventricular and ventricular tachycardias.
Moss et al. (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: